A Mexico City hospital is using artificial intelligence to detect breast lesions smaller than two millimeters [1].
This technology aims to identify tumors that are too small to be felt during physical exams, potentially saving lives through earlier intervention. In Mexico, breast cancer causes approximately 8,000 deaths every year [1].
The Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) implemented the system to enhance the accuracy of mammograms [1]. The AI analyzes imaging to find impalpable lesions, which are particularly difficult to spot in patients with dense breast tissue [1].
To assist radiologists, the system generates risk scores and utilizes color-coded maps to highlight areas of concern [1]. This visual guidance allows medical professionals to pinpoint anomalies that might be overlooked by the human eye during a standard review.
While the primary focus of the ISSSTE implementation is the detection of lesions under two millimeters [1], other reports on AI in oncology suggest these tools may identify cancer signals years before a radiologist can see them. The integration of these tools into public health systems represents a shift toward precision screening in the region.
The program is part of a broader effort to lower mortality rates by catching malignancies in their earliest stages [1]. By improving the sensitivity of mammography, the facility hopes to provide more patients with treatable diagnoses.
“AI detects lesions smaller than two millimeters”
The adoption of AI-assisted mammography by a public institution like ISSSTE indicates a move toward automating the 'first pass' of diagnostic imaging. By reducing the margin of error for impalpable tumors and dense tissue, the healthcare system can shift from reactive treatment to proactive early detection, which is the primary driver in reducing mortality rates for breast cancer.
